NASDAQ: KZR

Company Deals

Everest Medicines Partners with Kezar Life Sciences to Commercialize Zetomipzomib in Asia

Fineline Cube Sep 25, 2023

Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced a strategic collaboration and license...

Company

Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs

Company Drug

Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA

Company Drug

Belief BioMed and Takeda Win NMPA Approval for China’s First Hemophilia B Gene Therapy

Company Drug

Zai Lab’s Partner argenx Secures FDA Approval for Vygart Hytrulo Prefilled Syringe in gMG and CIDP